| ²é¿´: 164 | »Ø¸´: 0 | ||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | ||
[×ÊÔ´]
¼ÓÄôó·ÂÖÆÒ©É걨Êý¾ÝÇåµ¥-Summary of Submitted Data
|
||
|
Ŀ¼ÈçÏ£º 1.0 Information On Test Product 2.0 Information On Reference Product 3.0 Identification of Drug Characteristics and Dosage form Properties 4.0 Study Specific Product Information 5.0 Bioavailability Study Background Information 6.0 Summary of Study Design and Subject Information 7.0 Information on the Analytical Methodology and Analysis of Subject Samples 8.0 Summary of Drug Disposition and Pharmacokinetic Analysis ÏÂÔØµØÖ·£ºhttp://www.namipan.com/d/SUMMARY ... a46e2d7f50bd69d0000 |
» ²ÂÄãϲ»¶
WoSÒ»ÇøFrontiers in Genome Editing»ùÒò±à¼·½·¨ÓëÓ¦Ó÷½ÏòרÌâÑû¸å£¨Ó°ÏìÒò×Ó4.9£©
ÒѾÓÐ0È˻ظ´
WoSÒ»ÇøFrontiers in Genome Editing»ùÒò±à¼·½·¨ÓëÓ¦Ó÷½ÏòרÌâÑû¸å£¨Ó°ÏìÒò×Ó4.9£©
ÒѾÓÐ0È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ151È˻ظ´
WoSÒ»ÇøFrontiers in Genome Editing»ùÒò±à¼·½·¨ÓëÓ¦Ó÷½ÏòרÌâÑû¸å£¨Ó°ÏìÒò×Ó4.9£©
ÒѾÓÐ0È˻ظ´
WoSÒ»ÇøFrontiers in Genome Editing»ùÒò±à¼·½·¨ÓëÓ¦Ó÷½ÏòרÌâÑû¸å£¨Ó°ÏìÒò×Ó4.9£©
ÒѾÓÐ0È˻ظ´
Çó¹ºÊ±¼ä³¤Ò»Ð©µÄÏõËáîÊ
ÒѾÓÐ0È˻ظ´
Óг¥Ç󳦶¾ËصĴàÈõÄâ¸Ë¾ú£¨ETBF£©
ÒѾÓÐ0È˻ظ´
¹òÇóÒ»Ö§AAV293ϸ°û
ÒѾÓÐ1È˻ظ´














»Ø¸´´ËÂ¥
10